Genetics May Explain High COVID-19 Mortality in Italy, Inform Global Pandemic Response

Sbarro Health Research Organization (SHRO)

Newswise — On March 11th 2020 the World Health Organization declared Coronavirus disease (COVID-19) a pandemic. In a few weeks the infection spread across the globe causing hundreds of thousands of deaths worldwide. Italy was the first European country to be hard-hit by the infection and among the countries with a higher mortality rate. 

During the lockdown, Antonio Giordano, M.D., Ph.D., Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, in collaboration with the University of Siena, Italy, reasoned about the possible causes of the heavy burden of infection in Italy and teamed up with researchers from different fields to investigate the possible causes. In an Opinion article published today in Frontiers in Immunology, the authors describe the main features of COVID-19 clinical course; the possible underlying mechanisms that contribute to exacerbate patient outcome; and the various strategies that can be adopted to tackle the disease and its complications.

In particular, the authors, anticipating their preliminary findings, put the spotlight on the Human Leukocyte Antigen (HLA) gene system, which has a key role in shaping the antiviral - innate and acquired - immune response. The authors, including Pierpaolo Correale and Rita Emilena Saladino, of the Grand Metropolitan Hospital of Reggio Calabria, Giovanni Baglio, of the Ministry of Health, 

Francesca Pentimalli, of the National Cancer Institute ‘Pascale,” and Patrizia Maiorano, of the University of Siena, suggest that a specific immunogenetic asset constituted by particular variants of HLA genes could underlie susceptibility to the SARS-CoV-2 coronavirus, or predict a worse disease outcome. 

“The identification of such immunogenetic determinants would be crucial to inform priorities in future vaccination campaigns, to decide clinical management strategies, and to isolate genetically at risk individuals, including healthcare workers,” says Luciano Mutti, MD, Oncologist and Professor at the Sbarro Institute.

The study also raises another interesting possibility regarding the spreading of the infection in Italy, in which the northern region of the country, where the disease had been detected first, was most heavily hit. Although a massive migration from the affected regions to the south was recorded before the national lockdown, the southern regions registered much lower infection rates. However, it has been postulated that the virus was circulating long before the lockdown. While some have proposed that milder climate conditions could help to prevent viral spreading, could a specific immunogenetic asset contribute to protect southern Italian citizens? Further large-scale case-control studies will hopefully shed light on this possible aspect.


About the Sbarro Health Research Organization

The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3379
Released: 24-Sep-2020 5:05 AM EDT
Many Americans continue to maintain unhealthy lifestyle habits during COVID-19; overeating, alcohol drinking and marijuana use increase while exercise declines, reports USC Center for the Digital Future
USC Annenberg School for Communication and Journalism

After more than six months of living in a pandemic, large percentages of Americans continue to indulge in unhealthy lifestyle habits, including overeating and increased use of alcohol and marijuana — all while many are exercising less, according to a study of the cultural impact of COVID-19 conducted by the USC Center for the Digital Future (CDF).

Newswise: Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Released: 23-Sep-2020 4:55 PM EDT
Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Houston Methodist

Molecular analysis of COVID-19’s powerful second wave in Houston shows a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients tested at Houston Methodist since early March show a virus capable of adapting, surviving and thriving – making it more important than ever for physician scientists to understand its evolution as they work to discover effective vaccines and therapies.

Newswise: Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
Released: 23-Sep-2020 4:00 PM EDT
Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
University of Alabama at Birmingham

Researchers combined a lung-epithelial cell host interactome with a SARS-CoV-2 interactome. Network biology analysis of this human/SARS-CoV-2 interactome revealed potential molecular mechanisms of pathogenesis for SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

Newswise: Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect
Released: 23-Sep-2020 3:45 PM EDT
Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect
University of California San Diego Health

Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why.

Newswise: Flu Season Returns As The COVID-19 Pandemic Continues
Released: 23-Sep-2020 2:00 PM EDT
Flu Season Returns As The COVID-19 Pandemic Continues
Johns Hopkins Medicine

As the COVID-19 pandemic continues with no end in sight, the annual flu season emerges once again. Cases of the flu have already begun to surface around the nation, and there are some reports of co-infection with COVID-19. Johns Hopkins Medicine experts say now is the time to take action to fight against the flu. Doctors recommend that everyone age 6 months and older get the flu vaccine each year to prevent infection from the virus or reduce the severity of the illness.

Released: 23-Sep-2020 1:45 PM EDT
Mathematics: Modelling the timings of a COVID-19 second wave in Europe
Scientific Reports

How a second wave of COVID-19 infections may evolve across Europe over the next few months, using data on infection rates and travel within and between European countries, is modelled in a Scientific Reports paper.

Released: 23-Sep-2020 1:20 PM EDT
Study: Death counts fail to capture full mortality effects of COVID-19
University of South Florida

More than 200,000 people in the U.S. have died from COVID-19.

Released: 23-Sep-2020 1:10 PM EDT
Q&A: What’s in store for retailers during a pandemic holiday season?
Michigan State University

The 2020 holiday season, much like the majority of the year, will be like none other before. But what does this mean for retailers? Simone Peinkofer, assistant professor of supply chain management at Michigan State University’s Eli Broad College of Business, discusses what holiday consumerism may look like for consumers and retailers alike.

Released: 23-Sep-2020 1:05 PM EDT
UK lockdown and air pollution: Nitrogen dioxide halved but sulphur dioxide doubled
University of Liverpool

A University of Liverpool study of air pollution in the UK during the first 100 days of lockdown has revealed that whilst nitrogen oxide levels were cut by half, levels of sulphur dioxide increased by over 100%.

Released: 23-Sep-2020 1:05 PM EDT
Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials
Rutgers University-New Brunswick

As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.


Showing results

110 of 3379

close
0.97563